Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: Analog Kid who wrote (1059)	6/15/1998 11:49:00 AM
From: Alan M. Solinger	Read Replies (1) \| Respond to of 1115

My reading of the data from being involved in clinical and basic research for the last 20 years (in immunology) is that the data looks "statistically" significant, but not even close to what could be called "clinically" significant (commonly called "smoke and mirrors" - you can do a great deal with statistics if it is used inappropriately or ineptly). Remember, Dr. Katz has a long history behind him and anything he "touches" has to be evaluated with a "grain of salt". Wait till the FDA has a chance to review ALL of the data - not just what LIDAK upper management lets out in a controlled manner -- remember BUYER BEWARE!!!

To: Analog Kid who wrote (1059)	6/15/1998 4:36:00 PM
From: Red Dragon	Respond to of 1115

I also believe that the Lidak story is unfolding just as I cautioned in earlier posts in January. Lidakol is a neutral or marginally effective agent, but through statistical manipulations and deceptive statements, the company has managed to keep their head above water (barely). The clincher for me was when (1) Bristol Myers Squibb dumped Lidakol and walked away and (2) all the insider selling at 2 dollars a share. I warned many months ago that this stock is going to zero. It's just a matter of time. Forget about lawsuits, there is nothing left to recover. The market has reacted to the release of the Phase III data. It's not pretty. Consider getting 1 dollar a share now, rather than zero soon. exchange2000.com